Celiac Disease Foundation National Conference
May 5, 2018 11:00AM – 3:30PM
Pasadena Convention Center
Conference Center, Room 211

Where the brightest minds come together to share cutting-edge research about finding a cure.

The National Conference Package includes access to the EXPO Hall on Saturday, May 5 and Sunday, May 6.
Click here for more information about the EXPO.

The CDF National Conference is the premier educational conference on celiac disease and non-celiac gluten sensitivity. We bring together healthcare professionals, biopharmaceutical company representatives, and thought leaders to discuss cutting-edge research and advancements in diagnosing and managing celiac disease and non-celiac gluten sensitivity.

Have your questions answered by experts, mingle with patients facing similar struggles, and get the latest information about
celiac disease and non-celiac gluten sensitivity.

By purchasing this ticket you acknowledge the following: (1) Event tickets are a non-refundable donation to the Celiac Disease Foundation. (2) Strollers, carts, and wagons are prohibited, unless used for transporting children or medical equipment.
(3) Photo Release Form

Program Schedule

11:00 AM

Welcome

James J. Watson, Chairman of the Board of Directors

Marilyn G. Geller, Chief Executive Officer, Celiac Disease Foundation

Michael Karp, MD, FACP, Chief Department of Medicine, USC

Volunteer of the Year: Ariel Spiegelman

11:30 AM – 12:30 PM

From Symptoms to Diagnosis: What Your Doctor Really Thinks

Sheila Crowe, MD, FRCPC, FACP, FACG, AGAF, President, American Gastroenterological Association, UCSD

12:30 PM – 1:30 PM

 Living Gluten-Free to Live

 Janelle Smith, MS, RD, UCLA Medical Center

Jennifer A. Sealey-Voyksner, PhD, CSO, ImmunogenX

1:30 PM – 3:30 PM

Progress and Promise in the Treatment of Celiac Disease

Annette Taylor, MS, PhD, AVP, Director of Molecular Genetics, Esoterix Coagulation, LabCorp

David Winternheimer, PhD, PPM, CEO, Glutenostics

Francisco Leon, MD, Advisor, Celimmune

Wendy Perrow, MBA, Innovate Biopharmaceuticals

Jack A. Syage, PhD, CEO, ImmunogenX

Bob Anderson, BMedSC, MB, ChB, PhD, FRACP, CSO, ImmusanT

Please check back as more details become available.